Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

The nature, magnitude, and reporting compliance of device-related events for intravenous patient-controlled analgesia in the FDA Manufacturer and User Facility Device Experience (MAUDE) database.

Lawal OD, Mohanty M, Elder H, et al. The nature, magnitude, and reporting compliance of device-related events for intravenous patient-controlled analgesia in the FDA Manufacturer and User Facility Device Experience (MAUDE) database. Expert Opin Drug Saf. 2018;17(4):347-357. doi:10.1080/14740338.2018.1442431.

Save
Print
July 18, 2018
Lawal OD, Mohanty M, Elder H, et al. Expert Opin Drug Saf. 2018;17(4):347-357.
View more articles from the same authors.

This study reviewed mandatory reporting of patient-controlled analgesia device-related events to the Food and Drug Administration postmarketing surveillance database. Less that 10% of reported events were deemed adverse events, and the vast majority of these were preventable. The authors call for development and adoption of patient-controlled analgesia devices with improved safety features and better training.

Save
Print
Cite
Citation

Lawal OD, Mohanty M, Elder H, et al. The nature, magnitude, and reporting compliance of device-related events for intravenous patient-controlled analgesia in the FDA Manufacturer and User Facility Device Experience (MAUDE) database. Expert Opin Drug Saf. 2018;17(4):347-357. doi:10.1080/14740338.2018.1442431.